Buprenorphine Hydrochloride 72888-0183-30
- Manufacturer
- Advagen Pharma Ltd
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- June 10, 2015
- Listing Expires
- December 31, 2027
- Application
- ANDA090279
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 8 mg/1 |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Selected Package
72888-0183-30Selected30 TABLET in 1 BOTTLE (72888-183-30)
Other packages for this product(1)
90 TABLET in 1 BOTTLE (72888-183-90)